174 related articles for article (PubMed ID: 32157993)
41. The -308 bp TNF gene polymorphism influences tumor necrosis factor expression in leprosy patients in Bahia State, Brazil.
Oliveira JM; Rêgo JL; de Lima Santana N; Braz M; Jamieson SE; Vieira TS; Magalhães TL; Machado PRL; Blackwell JM; Castellucci LC
Infect Genet Evol; 2016 Apr; 39():147-154. PubMed ID: 26829382
[TBL] [Abstract][Full Text] [Related]
42. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
[TBL] [Abstract][Full Text] [Related]
43. Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports.
Thangaraju P; Venkatesan S; Gurunthalingam M; Babu S; T T
Rev Soc Bras Med Trop; 2020; 53():e20190454. PubMed ID: 32935774
[TBL] [Abstract][Full Text] [Related]
44. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
45. The impact of multiple drug therapy on leprosy disabilities.
Willcox ML
Lepr Rev; 1997 Dec; 68(4):350-66. PubMed ID: 9503872
[TBL] [Abstract][Full Text] [Related]
46. Adverse events in patients with leprosy on treatment with thalidomide.
Drummond PLM; Santos RMMD; Carvalho GO; Pádua CAM
Rev Soc Bras Med Trop; 2019 Apr; 52():e20180385. PubMed ID: 30994805
[TBL] [Abstract][Full Text] [Related]
47. Thalidomide levels in patients with erythema nodosum leprosum.
Vieira JL; Valente Mdo S
Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
[TBL] [Abstract][Full Text] [Related]
48. Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept.
Ramien ML; Wong A; Keystone JS
Clin Infect Dis; 2011 Mar; 52(5):e133-5. PubMed ID: 21292656
[TBL] [Abstract][Full Text] [Related]
49. Interventions for erythema nodosum leprosum.
Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
[TBL] [Abstract][Full Text] [Related]
50. Elevated Pentraxin-3 Concentrations in Patients With Leprosy: Potential Biomarker of Erythema Nodosum Leprosum.
Mendes MA; de Carvalho DS; Amadeu TP; Silva BJA; Prata RBDS; da Silva CO; Ferreira H; Hacker MA; Nery JAC; Pinheiro RO; Sampaio EP; Sarno EN; Schmitz V
J Infect Dis; 2017 Dec; 216(12):1635-1643. PubMed ID: 29272525
[TBL] [Abstract][Full Text] [Related]
51. Erythema leprosum--after treatment of Lepromatous Leprosy.
Eickelmann M; Steinhoff M; Metze D; Tomimori-Yamashita J; Sunderkötter C
J Dtsch Dermatol Ges; 2010 Jun; 8(6):450-3. PubMed ID: 19922466
[TBL] [Abstract][Full Text] [Related]
52. A Traditional NSAID Aspirin along with Clofazimine in Erythema Nodosum Leprosum Reaction: Study of Six Cases.
Sharma PK; Singh DK
Indian J Lepr; 2016 Sep; 87(4):249-253. PubMed ID: 29762954
[TBL] [Abstract][Full Text] [Related]
53. Experience With Anti-TNF-α Biologic Agents in Succession in Patients With Crohn's Disease: A Retrospective Analysis of a Single Center.
Ferges W; Rampertab SD; Shafqet M; Salimi Q; You G; Yousefzadeh E; Cheng JQ; Das KM
J Clin Gastroenterol; 2016 Apr; 50(4):326-30. PubMed ID: 25984976
[TBL] [Abstract][Full Text] [Related]
54. [Biologics and mycobacterial diseases].
Tsuyuguchi K; Matsumoto T
Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
[TBL] [Abstract][Full Text] [Related]
55. Household costs of leprosy reactions (ENL) in rural India.
Chandler DJ; Hansen KS; Mahato B; Darlong J; John A; Lockwood DN
PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003431. PubMed ID: 25590638
[TBL] [Abstract][Full Text] [Related]
56. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
Foss NT; de Oliveira EB; Silva CL
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
[TBL] [Abstract][Full Text] [Related]
57. A case of erythema nodosum leprosum reaction with diffuse alveolar haemorrhage, successfully treated by pulsed methylprednisolone.
Nakwan N; Thaichinda S; Nakwan N
Lepr Rev; 2010 Jun; 81(2):129-36. PubMed ID: 20825117
[TBL] [Abstract][Full Text] [Related]
58. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
[TBL] [Abstract][Full Text] [Related]
59. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
Benard G; Sakai-Valente NY; Bianconcini Trindade MA
Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
[TBL] [Abstract][Full Text] [Related]
60. Treatment of leprosy/Hansen's disease in the early 21st century.
Worobec SM
Dermatol Ther; 2009; 22(6):518-37. PubMed ID: 19889136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
